Category: Latest News
-
YD Bio Shares Spark Retail Trader Buzz Following Nasdaq Debut via Breeze SPAC
Retail investors showed strong interest in YD Bio (NASDAQ:YDES) late Sunday after the biotech firm announced it had finalized its merger with Breeze Holdings Acquisition Corp, a special purpose acquisition company (SPAC). YD Bio’s common shares and warrants started trading on the Nasdaq Global Market on Aug. 29 under the tickers YDES and YDESW, carrying…
-
U.S. dollar hovers near five-week low amid Fed caution, tariff uncertainty
The U.S. dollar remained close to a five-week low on Tuesday as investors assessed the likelihood of an upcoming Federal Reserve rate cut and ongoing uncertainty over U.S. trade tariffs. By 04:39 EST (08:39 GMT), the U.S. dollar index, which tracks the greenback against a basket of major currencies, had risen 0.6% to 98.30 but…
-
Gold retreats slightly after surging to record highs amid rate-cut speculation and tariff uncertainty
Gold edged lower on Tuesday after briefly hitting an all-time high, as markets reacted to ongoing expectations for U.S. interest rate cuts and uncertainty surrounding President Donald Trump’s trade tariffs. The precious metal remained in focus as investors sought safe-haven assets amid economic and policy concerns. Silver and platinum also posted strong gains, with silver…
-
Oil Holds Ground as Russia Supply Concerns Offset by OPEC+ Output
Oil prices remained largely unchanged in Tuesday’s Asian trading session, sustaining Monday’s gains as traders weighed risks of potential disruptions from the Russia-Ukraine conflict against rising production from OPEC+ nations. As of 21:03 ET (01:03 GMT), Brent crude for November delivery was trading 0.3% higher at $68.33 per barrel, following a more than 1% jump…
-
Dow Jones, S&P, Nasdaq, Wall Street Futures, Markets Slip as Gold Climbs, Nestle Faces Leadership Shake-Up
U.S. stock futures edged lower at the start of a holiday-shortened week, with investors closely watching upcoming economic releases that could signal the future direction of U.S. interest rates. Swiss food giant Nestle dropped after its CEO abruptly departed, while gold surged to record highs amid expectations of rate cuts and trade uncertainties. Futures Retreat…
-
Tesla’s India Debut Falls Short with Around 600 Orders – Bloomberg
Tesla Inc (NASDAQ:TSLA) has seen a modest response following its long-anticipated launch in India, Bloomberg reported Tuesday, with the electric car maker receiving just over 600 orders since mid-July. According to sources cited by Bloomberg, the figure falls below Tesla’s own projections and represents only a small portion of the company’s global sales this year,…
-
Global Stocks Extend Gains, Japan and Europe Outperform
The MSCI All Country World Index advanced 2.4% in August, supported by strong corporate earnings, growing expectations of interest rate cuts, and sustained enthusiasm for artificial intelligence, according to Bank of America. Since hitting a cyclical bottom on April 8, global equities have surged 28.1%. Japan has led the rebound, posting a 6.9% gain in…
-
SPAC News From The Last Seven Days
The Last Week’s Deals Alchemy Investments Acquisition Corp 1 (NASDAQ:ALCY) revealed plans to acquire Cartiga, LLC, technology-driven asset management platform that specializes in investing in legal claims and law firms. The transaction values Cartiga at about $540 million. The companies did not disclose a closing timeline. Inflection Point Acquisition Corp. III (NASDAQ:IPCX) reported a deal…
-
Dow Jones, S&P, Nasdaq, Five market themes to watch in the coming week
Markets enter a shortened trading week under the weight of ongoing legal disputes over U.S. tariffs, alongside anticipation for key economic data releases and corporate earnings. Investors will monitor employment figures, a series of business activity indicators, and the Federal Reserve’s “Beige Book,” while Broadcom and Salesforce are among the companies reporting results. Ongoing legal…
-
Wegovy Shows Superior Cardiovascular Safety Compared to Tirzepatide, Boosting Novo Nordisk Shares
Shares of Novo Nordisk (NYSE:NVO) rose over 2% on Monday after new real-world evidence indicated that its obesity treatment Wegovy (semaglutide) 2.4 mg lowered the risk of major cardiovascular events more effectively than Eli Lilly’s (NYSE:LLY) tirzepatide. The data, unveiled at the European Society of Cardiology Congress 2025 in Madrid, came from the STEER study,…